The US Food and Drug Administration had previously halted the company's test, which can show the potential risk of hereditary diseases.
On today's show, we check out an exoskeleton with FDA approval that's helping people walk again, freak out over Spider-Man's return to the Marvel Studios fold, and debate the usefulness of a fully robot-staffed hotel.
Rewalk is an exoskeleton designed to help paralyzed patients walk again. It's been approved for home and public use by the FDA for a while now, but we're just now seeing it for the first time, and we're excited about it.
FDA gives the nod to a 3D-printed facial implant that can be customized for individual patients in need of facial-reconstruction surgery.
Following the EU's lead, the US finally allows people with spinal cord injuries to buy the motorized system that lets them independently stand upright, turn, and walk.
People can still buy the genetic-testing startup's popular at-home testing kits, but they won't see any marketing for these products.
23andMe continues to sell its genetic sequencing tests despite a government order to stop.
Already approved by the FDA, the app is slated to debut in April to help diabetics make sure their blood sugar levels don't go too high or too low.
After more than 20 years in the making, the world's first FDA-approved bionic eye will soon be launching commercially in the United States. The device could help the tens of thousands of people who suffer from a rare, degenerative eye disease. CNET's Sumi Das explains how the Argus II device works to bring light into the darkness.
The FDA says it is only regulating products that turn smartphones into medical devices it already oversees, such as apps that let your phone act as an electronic stethoscope or give feedback on CPR.